Lauren Lee has spent the last 12 years working in the patient advocacy arena, specifically in rare kidney disease. She has been instrumental in creating a shared sense of purpose across multiple stakeholder groups that has helped drive therapeutic innovation forward. Lauren's current role is Executive Director of Patient Advocacy at Travere Therapeutics, a biotech focused on rare disease. Her responsibilities include nephrology and metabolic disorders advocacy strategy, voice of patient integration into workstreams, content development, and relationship building. In her role, she oversees the Rare Disease Patient Advisory Council (RDPAC) and serves as a liaison with several professional organizations including ASN. Prior to joining Travere, Lauren spent 10 years at NephCure where she learned from patient families and led several functions including industry engagement, patient education and programming, and research programs. In 2024, Lauren was recognized as a Luminary in Healthcare Businesswomen's Association Rising Stars and Luminaries. She holds a BA from Carleton University, Ottawa Ontario, and a master's degree from the Cooperstown Graduate Program in History Museum Studies.